Breast Cancer and hormonal contraceptive use
An estimated 64% of sexually active women in their reproductive years (between the ages of 15 and 49) make use of contraception worldwide. Hormonal contraceptives have well-known side effects such as venous thrombo-embolism, migraines, dizziness and fatigue. A study performed in Denmark and published in the NEJM(New England Journal of Medicine) in 2017 found its way into media and seemed to also draw a correlation between increased breast cancer risk and the use of hormonal contraceptives. This article unpacks those findings.